Comparison of diagnostic significance of the initial versus revised diagnostic algorithm for sarcopenia from the Asian Working Group for Sarcopenia

Tabara, Yasuharu; Ikezoe, Tome; Setoh, Kazuya; Sugimoto, Ken; Kawaguchi, Takahisa; Kosugi, Shinji; Nakayama, Takeo; Ichihashi, Noriaki; Tsuboyama, Tadao; Matsuda, Fumihiko

doi:10.1016/j.archger.2020.104071

Cited by 10 publications

(4 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A portable body composition analyzer from the Inbody models was confirmed as a reliable and valid tool to assess the SMM in healthy men and women and is considered to have sufficient ability to assess the body composition such as SMM, body fat, and body fat percent like other advanced models 43 . Moreover, the Inbody 430 has been widely used to assess SMM, especially for the Japanese population, in various studies, including large sample cohort studies [44][45][46][47][48] . After the participants wiped their soles off, they stood on the analyzer's platform, grasping the handles with both hands according to the manufacturer's guidance.…”

Section: Study Participantsmentioning

confidence: 99%

Bioelectrical impedance analysis to estimate one-repetition maximum measurement of muscle strength for leg press in healthy young adults

Sue

Kobayashi²,

et al. 2022

Sci Rep

View full text Add to dashboard Cite

Resistance training (RT) progress is determined by an individual’s muscle strength, measured by one-repetition maximum (1RM). However, this evaluation is time-consuming and has some safety concerns. Bioelectrical impedance analysis (BIA) is a valid and easy-to-use method to assess skeletal muscle mass (SMM). Although BIA measurements are often correlated with muscle strength, few studies of 1RM for RT and BIA measurements are available. This observational study examined the relationship between 1RM and BIA measurements and developed BIA-based prediction models for 1RM. Thirty-five healthy young Japanese adults were included. SMM and the skeletal muscle mass index (SMI) were measured using the BIA device. In addition, dominant-leg 1RM was measured using a unilateral leg-press (LP) machine. The correlations between BIA measurements and 1RM were calculated, and simple regression analyses were performed to predict 1RM from the BIA variables. The results showed significant correlations between 1RM and dominant-leg SMM (R = 0.845, P = 0.0001) and SMI (R = 0.910, P = 0.0001). The prediction models for 1RM for LP derived from SMM of the dominant leg and SMI were Y = 8.21x + 8.77 (P = 0.0001), R2 = 0.73, and Y = 15.53x − 36.33 (P = 0.0001), R2 = 0.83, respectively. Our results indicated that BIA-based SMI might be used to predict 1RM for LP accurately.

show abstract

Section: Study Participantsmentioning

confidence: 99%

Bioelectrical impedance analysis to estimate one-repetition maximum measurement of muscle strength for leg press in healthy young adults

Sue

Kobayashi²,

et al. 2022

Sci Rep

View full text Add to dashboard Cite

show abstract

“…Handgrip strength was measured alternately using a standard digital grip dynamometer (Grip-D; Takei Scientific Instrument Co., Ltd., Niigata, Japan, or YD, TTM, Tokyo, Japan) in a sitting position. The measurements were performed twice for each hand with the elbow extended and the arm position vertical to the ground, and the maximum value of all measurements was used for the analysis (Tabara et al, 2020).…”

Section: Measurement Of Physical Functionmentioning

confidence: 99%

Weak hip flexor strength predicts progression of functional capacity decline due to locomotor system dysfunction in community-dwelling older adults: A longitudinal cohort study

Ikezoe

Tsuboyama

Tabara

et al. 2021

Archives of Gerontology and Geriatrics

Self Cite

View full text Add to dashboard Cite

“…Recently, in a study based on 469,830 UK Biobank participants, associations of sarcopenia with adverse outcomes (all-cause mortality, incidence and mortality from cardiovascular disease (CVD), respiratory disease, and chronic obstructive pulmonary disease (COPD)) were strongest when sarcopenia was defined as slow gait speed plus low muscle mass, followed by severe sarcopenia, strongly suggesting that this combination of physical capability markers should still be considered in the diagnosis of sarcopenia [26]. The Asian Working Group for Sarcopenia studied the prevalence of 2061 older community residents (>60 years of age) [27]. Comparing the AWGS2014 algorithm to the revised AWGS2019 algorithm [28] (slow gait speed cut-off at <1 m/s and prolonged five-time chair-stand time (≥12 s)), the authors identified 60 and 89 individuals with sarcopenia, respectively.…”

Section: Introductionmentioning

confidence: 99%

Muscle Wasting and Sarcopenia in Heart Failure—The Current State of Science

Lena

Anker

Springer

2020

IJMS

View full text Add to dashboard Cite

Sarcopenia is primarily characterized by skeletal muscle disturbances such as loss of muscle mass, quality, strength, and physical performance. It is commonly seen in elderly patients with chronic diseases. The prevalence of sarcopenia in chronic heart failure (HF) patients amounts to up to 20% and may progress into cardiac cachexia. Muscle wasting is a strong predictor of frailty and reduced survival in HF patients. Despite many different techniques and clinical tests, there is still no broadly available gold standard for the diagnosis of sarcopenia. Resistance exercise and nutritional supplementation represent the currently most used strategies against wasting disorders. Ongoing research is investigating skeletal muscle mitochondrial dysfunction as a new possible target for pharmacological compounds. Novel agents such as synthetic ghrelin and selective androgen receptor modulators (SARMs) seem promising in counteracting muscle abnormalities but their effectiveness in HF patients has not been assessed yet. In the last decades, many advances have been accomplished but sarcopenia remains an underdiagnosed pathology and more efforts are needed to find an efficacious therapeutic plan. The purpose of this review is to illustrate the current knowledge in terms of pathogenesis, diagnosis, and treatment of sarcopenia in order to provide a better understanding of wasting disorders occurring in chronic heart failure.

show abstract

Comparison of diagnostic significance of the initial versus revised diagnostic algorithm for sarcopenia from the Asian Working Group for Sarcopenia

Cited by 10 publications

References 17 publications

Bioelectrical impedance analysis to estimate one-repetition maximum measurement of muscle strength for leg press in healthy young adults

Bioelectrical impedance analysis to estimate one-repetition maximum measurement of muscle strength for leg press in healthy young adults

Weak hip flexor strength predicts progression of functional capacity decline due to locomotor system dysfunction in community-dwelling older adults: A longitudinal cohort study

Muscle Wasting and Sarcopenia in Heart Failure—The Current State of Science

Contact Info

Product

Resources

About